Monday, Oct 18 2021 | Time 20:24 Hrs(IST)
image
Press Releases » prnewswire


Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%



MUMBAI, India, Sept. 21, 2021 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharmaceuticals Inc.


Glenmark Logo

According to IQVIATM sales data for the 12 month period ending July 2021, the Evoclin® Foam, 1%, market2 achieved annual sales of approximately 12.0 million*.


Glenmark's current portfolio consists of 173 products authorized for distribution in the U.S. marketplace and 47 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.


References:


1All brand names and trademarks are the property of their respective owners.


2Market includes brand and all available therapeutic equivalents


*IQVIATM National Sales Perspectives: Retail & Non-Retail, July 2021


About Glenmark Pharmaceuticals Ltd


Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. Glenmark's key therapy focus areas globally are respiratory, dermatology and oncology. It ranks among the world's top 50 Generics and Biosimilars companies (Top 50 Company Rankings, 2020, from Informa's Generics Bulletin). The company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the third consecutive year in a row. DJSI is one of the world's most respected and widely accepted sustainability benchmarks globally with only the top ranked companies in terms of Corporate Sustainability within each industry are featured in the index. For more information, visit www.glenmarkpharma.com 


Media Contact :

Udaykumar Murthy

Deputy General Manager

Corporate Communications

Glenmark Pharmaceuticals Ltd


Logo: http://mma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg



More News
HarperCollins presents verse from Shrimad Rajchandrajis: Atmasiddhi Shastra: Six Spiritual Truths of the Soul

HarperCollins presents verse from Shrimad Rajchandrajis: Atmasiddhi Shastra: Six Spiritual Truths of the Soul

18 Oct 2021 | 6:57 PM

HarperCollins presents verse from Shrimad Rajchandrajis: Atmasiddhi Shastra: Six Spiritual Truths of the Soul

see more..
Agri10x integrates with Polygon

Agri10x integrates with Polygon

18 Oct 2021 | 4:41 PM

Agri10x integrates with Polygon

see more..
Agri10x integrates with Polygon

Agri10x integrates with Polygon

18 Oct 2021 | 5:21 PM

Agri10x integrates with Polygon

see more..

Launching DhanLAP, Indias First Intelligent Digital Platform For Loan Against Mutual Funds

18 Oct 2021 | 4:50 PM

Launching DhanLAP, Indias First Intelligent Digital Platform For Loan Against Mutual Funds

see more..
Texila American University is a Top Choice to Pursue Medical Studies Abroad

Texila American University is a Top Choice to Pursue Medical Studies Abroad

18 Oct 2021 | 2:54 PM

Texila American University is a Top Choice to Pursue Medical Studies Abroad

see more..
image